Gelatin Microparticles

Liquid embolic agent based on advanced hydrogel technology for percutaneous or endovascular ablation of solid tumors. The agent is injected directly into cancerous lesions to induce tumor necrosis through mechanical obstruction and bioactive polymer interactions. Single-use sterile disposable for interventional oncology procedures.

Advanced embolic materials and devices for interventional procedures. Engineered to provide precise vascular occlusion and therapeutic intervention.

Microencapsulation technology utilizing collagen and gelatin for pharmaceutical applications. Enables controlled release and protection of sensitive active ingredients in medical formulations.

Absorbable gelatin sponge hemostatic device designed to control bleeding during surgical procedures. The sponge is applied directly to bleeding sites where it absorbs blood and promotes clotting through platelet aggregation. Made from purified gelatin with high absorbency capacity, it is resorbed by the body within 4-6 weeks, eliminating the need for removal.

Embolic microspheres designed for transarterial chemoembolization (TACE) and interventional oncology procedures. These spherical particles are injected through microcatheters to occlude tumor blood vessels and deliver therapeutic agents. Available in calibrated sizes for precise vascular embolization in hepatic and other tumor interventions.

A hemostatic product for otolaryngology applications. It is designed to assist in controlling bleeding during ENT procedures.

Medical balloons designed for vascular embolization and hemostatic procedures. Available with surface coatings for enhanced thrombogenicity.

Injectable tetra gel formulation for minimally invasive tissue repair, regeneration, and drug delivery in orthopedic and soft tissue applications.

A composite hydrogel material specifically designed for integration with cell-based therapeutic approaches. The formulation supports cell viability and functionality while providing structural biocompatibility. Developed according to ISO 10993 and international biocompatibility evaluation standards.

A double velvet mesh vascular graft material for vascular reconstruction procedures.

Patented PGS polymeric biomaterial that mimics natural tissue environment and supports cell development without triggering inflammatory response. Used as foundation for various implantable medical devices.

Devices for vascular embolization and therapeutic occlusion. These products enable controlled vascular closure in interventional procedures.